Results 171 to 180 of about 24,569 (232)

Vasoprotective effects of lysophosphatidic acid inhibit vascular injury caused by SARS-CoV-2 infection. [PDF]

open access: yesSci Rep
Muramatsu F   +12 more
europepmc   +1 more source

Cancer therapy-related cardiotoxicity is associated with distinct alterations of the myocardial lipidome. [PDF]

open access: yesEur J Heart Fail
Braun VM   +6 more
europepmc   +1 more source

Multiple LPA<sub>3</sub> Receptor Agonist Binding Sites Evidenced Under Docking and Functional Studies. [PDF]

open access: yesInt J Mol Sci
Solís KH   +5 more
europepmc   +1 more source

Exogenous phosphatidylserine protects against mesenteric ischemia-reperfusion with associated Akt/mTOR pathway upregulation. [PDF]

open access: yesSci Rep
Hamaneh AM   +9 more
europepmc   +1 more source

Comparative Analysis of Lysophosphatidic Acid Levels in Fibromyalgia and Other Painful Conditions in Female Patients. [PDF]

open access: yesEur J Pain
Menezes J   +10 more
europepmc   +1 more source

Generation of New Knock-Out Mouse Strains of <i>Lysophosphatidic Acid Receptor 1</i>. [PDF]

open access: yesInt J Mol Sci
Antonopoulou G   +6 more
europepmc   +1 more source

The effect of lysophosphatidic acid on myometrial contractility and the mRNA transcription of its receptors in the myometrium at different stages of endometrosis in mares. [PDF]

open access: yesBMC Vet Res
Piotrowska-Tomala KK   +7 more
europepmc   +1 more source

GPR35 mediates monocyte recruitment to the sites of Listeria monocytogenes infection. [PDF]

open access: yesCell Mol Life Sci
Okamura Y   +10 more
europepmc   +1 more source

Molecular Dynamics (MD) Simulation of GPR87-LPA Binding: Therapeutic Implications for Targeted Cancer Treatment. [PDF]

open access: yesAnticancer Agents Med Chem
Rani M   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy